Special Issue: Human genome at 20

February 04, 2021

In February 2001, the first drafts of the human genome were published. In this Special Issue of Science, "Human Genome at 20," an Editorial, a Policy Forum, a series of NextGen Voices Letters and a Perspective explore the complicated legacy of the Human Genome Project (HGP). "Millions of people today have access to their personal genomic information, with direct-to-consumer services and integration with other 'big-data' increasingly commoditizing what was rightly celebrated as a singular achievement in February 2001," writes Science Senior Editor Brad Wible.

An Editorial by Claire Frasier, director of the Institute for Genome Sciences at the University of Maryland School of Medicine, provides her reflections on how far genomic science has come since the HGP was first launched. A series of NextGen Voices Letters provides stories from young scientists who've had their own genomes sequenced using consumer DNA ancestry tests. They reflect on how they understand their genetic history in the context of their family traditions, cultures and lived experiences. In a Policy Forum, a collection of experts weighs in on fruits of the HGP, as well as missteps and growing pains resulting from related endeavors that point to challenges that remain. These will require scientists to focus on rapid and open sharing of genetic data; increase diversity in genome science; encourage more Indigenous Peoples to participate in genomics research; address bias in the algorithms that analyze genomic data, and develop a multidisciplinary approach for developing and implementing polygenic risk scores for diverse communities. Finally, in a Perspective, Namandjé Bumpus argues that the lack of diversity in clinical trials hinders the ability to fully understand variation and predict drug outcomes across populations, including those at most risk for a disease. For many decades, most clinical trials in the U.S. have been carried out primarily on individuals of European descent - a trend that largely continues today. However, if the key goal of clinical testing is to ensure a drug's safety for everyone, genetic variation across populations must be accounted for. "Recognizing and acting on the need to diversify clinical trials is an important way to ensure that treatments are most likely to work for all people and that existing health disparities and the costs they bring are not further exacerbated," writes Bumpus.
-end-


American Association for the Advancement of Science

Related Human Genome Articles from Brightsurf:

240 mammals help us understand the human genome
A large international consortium led by scientists at Uppsala University and the Broad Institute of MIT and Harvard has sequenced the genome of 130 mammals and analysed the data together with 110 existing genomes to allow scientist to identify which are the important positions in the DNA.

The National Human Genome Research Institute publishes new vision for human genomics
The National Human Genome Research Institute this week published its 'Strategic vision for improving human health at The Forefront of Genomics' in the journal Nature.

Interpreting the human genome's instruction manual
Berkeley Lab bioscientists are part of a nationwide research project, called ENCODE, that has generated a detailed atlas of the molecular elements that regulate our genes.

3-D shape of human genome essential for robust inflammatory response
The three-dimensional structure of the human genome is essential for providing a rapid and robust inflammatory response but is surprisingly not vital for reprogramming one cell type into another.

The genome of chimpanzees and gorillas could help to better understand human tumors
A new study by researchers from the Institute of Evolutionary Biology (IBE), a joint center of UPF and the Spanish National Research Council (CSIC), shows that, surprisingly, the distribution of mutations in human tumors is more similar to that of chimpanzees and gorillas than that of humans.

It's in our genome: Uncovering clues to longevity from human genetics
Researchers from Osaka University found that high blood pressure and obesity are the strongest factors reducing lifespan based on genetic and clinical information of 700,000 patients in the UK, Finland and Japan.

New limits to functional portion of human genome reported
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.

Synthesizing the human genome from scratch
For the past 15 years, synthetic biologists have been figuring out how to synthesize an organism's complete set of DNA, including all of its genes.

Science and legal experts debate future uses and impact of human genome editing in Gender & the Genome
Precise, economical genome editing tools such as CRISPR have made it possible to make targeted changes in genes, which could be applied to human embryos to correct mutations, prevent disease, or alter traits.

Evolution purged many Neanderthal genes from human genome
Neanderthal genetic material is found in only small amounts in the genomes of modern humans because, after interbreeding, natural selection removed large numbers of weakly deleterious Neanderthal gene variants, according to a study by Ivan Juric and colleagues at the University of California, Davis, published Nov.

Read More: Human Genome News and Human Genome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.